公开(公告)号：US20210213263A1

公开(公告)日：2021-07-15

申请号：US17270424

申请日：2019-08-23

申请人： BAYWIND BIOVENTURES

发明人： Christopher A. Rhodes ,  Jose Casillas

IPC分类号： A61M31/00 ,  A61K9/00 ,  A61K9/48 ,  A61K9/46

摘要： Various embodiments of an oral delivery capsule device for delivering an active agent to a part of a gastrointestinal (GI) tract of a subject are described. The capsule device may include a capsule body configured to travel along the GI tract. The capsule device may include a reservoir configured to contain an active agent for delivery to the GI tract of the subject. The oral delivery capsule device may include an actuation feature configured to provide a delivery force thereby causing the dispensing of the active agent. The oral delivery capsule device may include an actuation control feature configured to prevent actuation of the actuation feature under a first condition and allow actuation under a second condition. Related systems and methods are also described.

公开(公告)号：US12128201B2

公开(公告)日：2024-10-29

申请号：US17270424

申请日：2019-08-23

申请人： BAYWIND BIOVENTURES

发明人： Christopher A. Rhodes ,  Jose Casillas

IPC分类号： A61M31/00 ,  A61K9/00 ,  A61K9/46 ,  A61K9/48

CPC分类号： A61M31/002 ,  A61K9/0007 ,  A61K9/0065 ,  A61K9/0097 ,  A61K9/4808 ,  A61K9/4891 ,  A61M2205/0238 ,  A61M2205/3324 ,  A61M2210/1042

摘要： An oral delivery capsule device for delivering an active agent to a part of a gastrointestinal (GI) tract of a subject may include a capsule body configured to travel along the GI tract. The capsule device may include a reservoir configured to contain an active agent for delivery to the GI tract of the subject. The oral delivery capsule device may include an actuation feature configured to provide a delivery force thereby causing the dispensing of the active agent. The oral delivery capsule device may include an actuation control feature configured to prevent actuation of the actuation feature under a first condition and allow actuation under a second condition.